FUNDING SIGNALS

Real Signals. Real Leads. Real Deals.

The only platform that turns real-time signals into your perfect leads

Know Who, Why, and When to reach out — instantly.

FundzWatch™ AI Scoring

10-25 leads daily

Real-time alerts

★★★★★

4.8/5 on G2• High Performer Fall 2025

Used by teams at LinkedIn, HubSpot & Oracle

🔒 app.fundz.net

TechCorp

📍 San Francisco👥 85

Post-Funding

⭐ Ideal Match

Just raised $40M Series B - high purchase intent window

Pinetree Therapeutics, Inc. Secures $23.5 Million Of Series A1 Funding To Develop Cutting Edge Platform Technology To Create Therapeutic Assets For Unmet Medical Needs

Jun 07, 2022•over 3 years ago

Amount Raised

$23.5 Million

Round Type

series a

Description

PineTree Therapeutics, Inc., an emerging leader in pioneering the development of disruptive therapies in Oncology, Immuno-oncology and other diseases, announced that the company has raised $23.5 Million for Series A1 funding. The investments, which will be used to advance our Oncology and Viral Diseases platforms, were made by InterVest, SK Securities, DSC Investment, J Curve Investment, Samho Green Investment, and SJ Investment Partners.

Company Information

Company

Pine Tree Therapeutics

About

PineTree Therapeutics, Inc., an emerging leader in pioneering the development of disruptive therapies in Oncology, Immuno-oncology and other diseases, announced that the company has raised $23.5 Million for Series A1 funding. According to HoJuhn Song, Co-Founder and CEO of PineTree Therapeutics, the company has developed a highly differentiated platform to solve the world's difficult-to-treat diseases, which require unconventional approaches to deliver a new paradigm on providing real and meaningful benefits for patients. The firm gained its early reputation from successful invests into Biotech ventures such as ABL bio. About PineTree Therapeutics, Inc.PineTree Therapeutics is a pre-clinical stage Biotech company headquartered in Cambridge, MA and was founded in 2019.

Company News

(3 articles)

Tue, 01 Jul 2025 07:00:00 GMT

Leveraging crude extracts from European tree bark to combat oxidative stress, enhance wound healing, and inhibit pathogenic bacterial growth - Nature

Wed, 22 Dec 2021 08:00:00 GMT

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients - NEJM

Fri, 30 Jan 2015 08:00:00 GMT

Forest bathing: what it is and where to do it - National Geographic

FundzWatch™ Score

Medium Activity

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech